Thierry DeBaere, MD

Faculté médecine Paris Sud

CURRICULUM VITAE
Prof. Thierry de Baere
Professor of medicine
University Paris Sud, Paris, France

Head of department of intreventional radiology
Institut Gustave Roussy
PROFESSIONAL DETAILS

Full time dedicated to interventional oncology at Institut Gustave Roussy since 1991. Excellent collaboration with surgery and medical oncology teams, acive member of toumor board, allowing to develop many synergistic treatments, including optimization of various intra-arterial therapies for primary and secondary liver tumors and locoregional therapies for innovative cancer treatment.

RESERACH AND SPECIAL INTEREST:
- Portal vein embolization
- intra-arterial therapy for liver cancer
- Percutaneous ablationin lung, liver and bones
- Image guidance for IR
- local immuno-oncology

Principal Investigator of several international studies on ablation, intraarterial therapies, combined therapies and other innovative locoregional treatments

SCIENTIFIC COMMITTEES

Chairman of standard of practice committee at CIRSE board 2007-2009
Chairmann of the program committee ECIO 2012/2013/2014/2015
Member of the ESIR scientific committee.
Member o fthe oncology alliance committee at CIRSE

- EDITOR ONCOLOGY Cardiovascular and Interventional Radiology

PUBLICATIONS

Over 270 peer reviewed publications, cited in morethan 6000 following scientific publications.

Presentation(s):

• Palliation of Painful Bone Metastases: How Do You Choose Between Ablation, Embolization, HIFU or Radiation?

  Friday, May 10
  8:10 AM – 8:20 AM

• Hands-on Workshop: Imaging II

  Friday, May 10
  10:30 AM – 12:00 PM

• What We Can Learn From Negative Radioembolization Trials for HCC

  Saturday, May 11
  10:40 AM – 10:50 AM

• Geographical Differences and Etiologies Impact the Role of IR in Advanced HCC

  Saturday, May 11
  11:00 AM – 11:05 AM

• Portal Vein Thrombosis Complicates But Does Not Preclude LDT

  Saturday, May 11
  11:05 AM – 11:10 AM

• Early HCC: How to Choose the Right Option?

  Saturday, May 11
  11:30 AM – 11:40 AM

• Technical Advancements for Better TACE: Very rapid resorbable, slow resorbable, Permanent particles: Does that matter?

  Saturday, May 11
  11:50 AM – 11:55 AM

• Technical Advancements for Better TACE: Does Lipiodol/Alcohol TACE Need to Be Validated?

  Saturday, May 11
  11:55 AM – 12:00 PM

• Liver Directed Therapy for NET Liver Metastases: How Do You Choose?

  Saturday, May 11
  2:50 PM – 3:00 PM